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Abstract
The number of methods for pre-processing and analysis of gene expression data continues to increase, often making it
difficult to select the most appropriate approach. We present a simple procedure for comparative estimation of a variety of
methods for microarray data pre-processing and analysis. Our approach is based on the use of real microarray data in which
controlled fold changes are introduced into 20% of the data to provide a metric for comparison with the unmodified data.
The data modifications can be easily applied to raw data measured with any technological platform and retains all the
complex structures and statistical characteristics of the real-world data. The power of the method is illustrated by its
application to the quantitative comparison of different methods of normalization and analysis of microarray data. Our
results demonstrate that the method of controlled modifications of real experimental data provides a simple tool for
assessing the performance of data preprocessing and analysis methods.
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Introduction
The number of methods available for pre-processing and
analysis of high-dimensional data continues to increase, making a
comparative assessment of the performance of these various
methods increasingly important. Such a comparison should be
qualitative, as well as time-, computation- and cost effective.
Currently, no commonly accepted rules exist for such comparative
testing. The performance of each test should be characterized in
terms of the test’s ability to distinguish true changes from noise
that appears to represent a pattern. The receiver operating
characteristic (ROC) curve, which represents all possible combi-
nations of the relative frequencies of the various kinds of correct
and incorrect decisions, is usually employed as a simple empirical
description of these characteristics [1,2,3]. The ROC-curve
presents the relationship between sensitivity and specificity and
can be used to characterize the overall performance of different
arrays and the software designed for data acquisition on the
different platforms. However, the lack of simple inferential
procedures to discriminate between true and false selections has
limited the practical utility of ROC curve analysis. Generation of
the decision rules used to estimate the proportions of true and false
selections requires knowledge of the distribution of these
categorical assessments, which is not provided by the tests
themselves. Neither visual inspection of the array images [4] nor
the use of differences between perfect matches and mismatches on
Affymetrix arrays provides an objective measurement to make
these discriminations.
One promising approach is based on the use of a simulation
strategy that constructs more-or-less realistic data models with
varying statistical characteristics that reflects the properties of real
gene expression data [5,6,7,8,9]. However, such approaches are
not fully satisfactory because they rely on model assumptions that
are not necessarily supported by empirical studies. The true
changes in expression are not known beforehand and largely differ
between each experimental situation. Thus, these changes in
expression cannot be characterized and used for evaluation a priori,
and such comparison approaches do not guarantee complete
similarity between the structure of the simulated data and complex
real-world expression data. The most objective discrimination
between false and true changes in a dataset was achieved by using
a ‘‘spike-in’’ experimental procedure based on Affimetrix Gene-
Chip technology [10,11,12]. This approach generated objectively
different signals by changing the mRNA concentration in a
controlled quantitative manner. Data from spike-in experiments
(where the mRNA-ratios of a set of artificial clones are known) can
be used to determine the relative merits of a set of analysis
methods [13,14]. The design of a spike-in experiment must be
based on assumptions as to how real microarray data behave.
These assumptions are generally less restrictive than those
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approach remains expensive, time consuming and inflexible, thus
limiting its utility.
We propose a simple approach to assessing various methods of
data analysis that is based on the use of real microarray data. Our
assessment can be easily implemented into the design of any
microarray experiment and can be performed with minimal
training. It is important to note that our approach is applicable to
any microarray dataset generated from homogenous groups of
samples hybridized to the arrays.
The first step in our strategy is the introduction of controlled
changes into homogeneous group of microarray data. The group
is split into two equal subgroups, one of which remains unchanged
and is used as a standard for comparison. The second subgroup is
altered by introducing controlled fold changes in the gene
expression values. Similar step - introduced changes in the real
gene expression data - was used earlier for demonstration of the
breakdown of Lowess normalization after ‘‘one direction changes’’
[15]. Our implementation introduces these controlled fold changes
homogenously over the entire range of gene expression levels. This
modification was applied to 5–20% of the entire dataset, thereby
retaining the complex structure and statistical characteristics of the
remainder of the data.
We illustrate the application of this method for an optimal cutoff
estimation, intensity-based filtering and for optimal fold differences
selection that provides the highest ratio of true to false signals. This
method enables us to estimate the degree to which the quality of
the analysis depends on the level of gene expression. Our method
estimates the minimal necessary number of replicates to achieve an
expected sensitivity in the differential gene expression analysis. We
also applied our approach to the comparative estimation of the
quality of data preprocessing (normalization) and the performance
of the methods of differential gene expression analysis.
Materials and Methods
Global gene expression profiling
We performed gene expression profiling from 20 samples of
Epstein-Barr Virus-transformed B cells collected from normal
healthy donors. RNA was isolated using Ambion’s RNAqueous
RNA isolation kit (Ambion Inc., TX) according to the manufac-
turer’s protocol. After purification, RNA concentration was
determined with a Nanodrop scanning spectrophotometer.
Illumina Whole Genome Human Ref-8 v2.0 arrays containing
,24,000 probes were handled according to standard protocols
established by the manufacturer. Briefly, 200ng of total RNA from
each sample were used to generate biotin-labeled cRNA probes
using an Illumina MessageAmp cRNA labeling kit protocol
(Ambion). Quality control of the cRNA was performed using an
Agilent Bioanalyzer and a Nanodrop. Labeled cRNA probes were
hybridized to Illumina arrays and images were obtained on an
Illumina Beadchip scanner. The images and raw data from each
chip were transferred automatically to the microarray database
using one of the specified microarray core servers. The raw data is
available on GEO [16] (GSE22630 accession number) and in
Supplemental Table S1.
Microarray data analysis
Our methods for data normalization and analysis are based on
the use of ‘‘internal standards’’ [17] that characterize some aspects
of the system’s behavior, such as technical variability, as presented
elsewhere [18,19]. In general, an internal standard is constructed
by identifying a large family of genes that behave similarly. Genes
expressed below technical sensitivity represent one example of an
internal standard. This group of genes comprises a background
cohort that conforms to the parameters of normal distribution.
Another example is a group of genes with similar expression
patterns across several distinct experimental conditions, denoted as
an equally expressed cohort. These internal standards are used to
robustly estimate parameters that describe some features of the
experimental system, such as the pattern of genes expressed
distinctly from background, cohort of stably expressed genes, or
genes displaying similar dynamic behavior.
Two-step normalization procedure. The first step is
determination of the parameters of a background of an array –
average (Av) and standard deviation (SD) – is performed using a
special iteration procedure. Data in each array are transformed to
make these parameters equal to 0 and 1, correspondingly. After
this transformation gene expression data are presented in the units
of standard deviation of the background. We accept the threshold
of 3 SD above the mean of background distribution as the
preliminary criterion for distinguishing between expressed and
non-expressed genes. Only genes expressed above background are
used for the second step.
The second step is the adjustment of normalized profiles to each
other by robust linear regression. This procedure is based on the
selection of equally expressed genes as a homogenous family of
genes with normally distributed residuals defined as deviations
from the regression line. The parameters of this distribution are
obtained by the iterative procedure similar to one used for the
selection of normally distributed background noise. Outliers are
thereafter determined as having deviations not associated with
this internal standard of equality of expression.
The differential gene expression analysis – Associative analysis
[18,19] - includes the following steps:
– Construction of the ‘reference group’ by identifying a group of
genes expressed above background with inherently low
variability as determined by an F-test. The ‘reference group’
presents an internal standard of equal expression. As such, the
‘reference group’ is used to assess the inherent variability
resulting from technical factors alone (technological variation).
By creating an estimate of the technological variation we are
able to select a group of biologically stable genes.
– Selection of replicates using the commonly accepted signifi-
cance threshold of p,0.05 with a Student T-test. This selection
maintains the commonly accepted sensitivity level; however, a
significant proportion of genes identified as differentially
expressed at this threshold will represent false positive
determinations.
– An Associative T-test in which the replicated residuals for each
gene from the experimental group are compared with the
entire set of residuals from the reference group defined above.
The Ho hypothesis is checked to determine whether the levels
of gene expression in the experimental group presented as
replicated residuals (deviations from the averaged control
group profile) is associated with a highly representative (several
hundred members) normally distributed set of residuals of gene
expression values in the reference group. The significance
threshold is then corrected to render the appearance of false
positive determinations improbable. Only genes that pass both
tests are presented in the final selections.
The two-step normalization procedure and the Associative
analysis functions are implemented in MatLab (Mathworks, MA)
and available from authors upon request. These algorithms are
also obtainable from an R package diffGeneAnalysis, available as a
part of Bioconductor packages (http://www.bioconductor.org/
Performance of Analyses
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ductor packages (affy, limma, vsn) were used for Quantile, Lowess
and VSN data normalization and for Limma analysis. SAM:
Significance Analysis of Microarrays was used as an Excel add-on,
downloaded from http://www-stat.stanford.edu/,tibs/SAM/.
Introduction of balanced changes into the gene
expression data
In this study, we used gene expression data from 20 total RNA
samples from Epstein-Barr Virus-transformed B cells collected
from normal healthy donors. This presumably homogenous
group of samples was sorted by average expression level and split
into two equal subgroups, designates as ‘‘control’’ and ‘‘exper-
imental’’. The data was then split into blocks of 1,000 genes each.
Controlled balanced (+/2) changes were introduced into 20% of
the data in the experimental subgroup. One hundred genes in
each 1000 gene block were modified by a positive change
(multiplied by fold change) and another hundred genes were
modified by a negative change (divided by fold change). The top
thousand genes with the highest expression levels were treated
slightly differently: they were split into five 200-gene blocks, and
within each of them 20 genes were modified by positive change
(multiplied by fold change) and 20 genes were modified by
negative change (divided by fold change) (data with color-coded
modifications used in this paper are presented in Supplemental
Tables S2, S3, S4, S5 and S6). The rationale behind it is that a
very wide range of gene expression changes present at the highest
expression levels (Figure 1). Therefore, more detailed controlled
changes are necessary to better assess performance dependence of
an analysis from expression level.
The altered genes are denoted as all positive genes (AP-genes) in
contrast to the remaining genes that were initially not changed (all
negative – AN-genes). One block of AP/AN genes is shown on
Figure 1B. The modification did not noticeably alter the frequency
distribution histogram of the data (data not shown), as would be
expected from the relatively modest amount of change (20% of
genes altered). After applying the analysis procedure, the resulting
selections are compared with the AP- and AN-genes for
determination of the Sensitivity and Specificity of a given analysis.
Sensitivity and Specificity can be expressed using known numbers
of true and false positive and negative selections. Here, true
positives (TP) are selections made in the course of differential
expression analysis among the AP-genes. True negatives (TN) are
genes that were not selected as differentially expressed among the
AN-genes. False positives (FP) are genes selected in the course of
analysis as differentially expressed from the AN-genes. False
negatives (FN) are AP-genes not selected as differentially
expressed. Given these definitions, we derived the following
Figure 1. Test system for determination of the Sensitivity and specificity of the differential gene expression analyses. A supposedly
homogeneous group of samples was divided into two equal subgroups, one of which was not changed and used as a control and the other used as
an experimental group with introduced changes (Supplemental Tables S2, S3, S4 and S5). All data (,20,000 genes) were divided into 20 equal blocks.
A) A fragment of experimental data set. The data are sorted according the averaged level of expression (green line, shown relative to the maximum
expression level units). The figures on the left side of vertical axis show the positions of each block (in percents of the total data). Positive (red) and
negative (blue) changes were introduced in the 20% portion of genes in the block (usually changes applied to the genes with highest expression in
each block, excluding the first one containing the very first 100 genes with highest expression levels. Here 40 differentially expressed genes created
within each of five 200 gene segments). B) Structure of one of the blocks (90–95% of data). Left vertical axis presents positions of positive (red) and
negative (blue) introduced changes with the rest (green) positions of unchanged gene expressions. Right vertical axis shows selections made by an
analysis: red/blue – correct selection of +/2 changes, yellow/light blue – false selection of +/2 changes among not changed genes, green marked FN
– false negative selections (not identified + or 2 changes), green marked TN – true negative selections. Sensitivity of selections is determined here as
a proportion of true positive selections within all produced changes, Specificity determined as a a proportion of true negative selections among all
unchanged genes, and Precision is determined as a proportion of true positive selections among all selections made by an analysis, or as a value
whose deviation from 1 is associated with the presence of false positive selections.
doi:10.1371/journal.pone.0012657.g001
Performance of Analyses
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12657equations (4):
Sensitivity~
TP
TPzFN
~
TP
AP
Specificity~
TN
AN
~1{
FP
AN
However, the use of Specificity expression as presented here was
not particularly useful for characterizing the quality of microarray
data analyses. The problem with this metric is that in any
microarray analysis, the number of AN-genes always exceeds the
number AP-genes by at least several fold. As a result, a significant
number of false negative selections will produce only a small
deviation from 1 in Specificity value. For example, if there are two
hundred differentially expressed genes from twenty thousand total
genes measured in an array, selection of ten false positives will
result in a Sensitivity of 0.95. In contrast, the same number of false
negatives will produce a Specificity value of 0.999. This Specificity
value does not express the real impact of this number of selected
false negatives, which should be more comparable to the impact of
false positive selections. To improve this situation, we used instead
the Precision parameter, which is a better characteristic for testing
exactness or fidelity in cases with significant differences in sizes of
positive and negative numbers. Accordingly [20], Precision is
calculated as follows:
Precision~1{
FP
TPzFP ðÞ
with reciprocal dependence on FP and approaching 1 when FP is
close to zero. Now both Sensitivity and Precision are presented
symmetrically in the proportions of the true/false positives to all
selections.
To estimate stability of the proposed characteristics, our test
procedure can be repeated several times with random permutation
of the order of samples within the group before each split. The
averaged Specificity and Precision parameters from multiple tests,
together with their Standard Deviations, are presented in the
figures.
Results
Influence of fold change and expression level restrictions
on the quality of analysis
The data that include controlled balanced changes in the
expression levels of a small proportion of the genes in the array can
be used for a variety of purposes, including comparison of different
methods of data pre-processing and analysis. We begin, however,
with a demonstration of the potential of this method for estimation
of the effects of different restrictions frequently used in differential
gene expression analyses.
The step typically following completion of a differential gene
expression analysis using strong statistical criteria is to focus on the
most prominent changes. To achieve this some additional
restrictions are applied, such as minimal level of expression and
the fold changes in the level of expression deemed biologically
significant. The influence of these pre-processing steps on the
quality of analysis has not been extensively studied.
Filtering by a minimum expression level obscures the influence
of extreme variability of low expressed genes. Additionally,
filtering out genes that are expressed only at low levels
unambiguously demonstrates that the most important biological
changes are usually well represented by genes with high expression
level. However, the cost of this restriction is that changes in
regulatory genes expressed at low levels, such as transcription
factors [21,22], may be lost.
Statistical analysis of differences in gene expression can identify
even minimal changes in levels of gene expression if those changes
are extremely stable across replicated experiments. However, the
statistical significance of a fold change does not necessarily reflect
biological relevance. Genes with low fold change differences
should certainly be excluded, at least at the stage of initial
examination of the results. Those genes displaying high fold
changes in gene expression (and, hence, in mRNA abundance)
potentially represent the most important functions in the biological
system. We refer to these as ‘‘beacon genes’’ [23]. At the same
time, changes in the expression/activity of regulatory genes, which
are usually neither highly expressed nor display prominent
variations in expression levels, may represent important biological
characteristics of the system. Traditional filtration on a minimal
level of expression and fold change will exclude these genes from
initial examination. However, these genes may be considered at
later stages of the analysis to clarify the biology behind gene
expression changes.
To estimate the influence of fold change and expression level
restrictions on the quality of analysis, we used the data described in
the Materials and Methods as a presumably homogenous group of
20 samples split into two equal subgroups. One of the subgroups
remained unchanged (control) and the other was subjected to the
procedure of balanced changes described above (Table S2, S3, S4,
S5 and S6). Data were Two-Step normalized and the same
method of analysis – Associative analysis of differential gene
expression [19] – was used for all comparisons.
Figure 2 shows the effect of introduced fold change (Fd),
restriction on the minimum fold change (Fa) and expression level
(Em) on the Sensitivity and Precision of the differential expression
analysis. Sensitivity is by far most affected by the choice of these
parameters, whereas Precision remains relatively stable across all
values. Deviation of these parameters from optimal values first
leads to loss of positive selection. The procedure for selecting
differentially expressed genes in the Associative analysis includes
these restrictions. Violation of even one of them results in
exclusion of that gene from the list of differentially expressed
genes. This behavior explains why Sensitivity decreases as
parameters of the analysis are changed. Naturally, it follows that
under these conditions, it is more difficult to create conditions
leading to increased levels of false positives. As a result, the
Precision of the analysis method is more robust to variation in
these restriction conditions.
Figure 2A demonstrates that the use of the same restrictions on
the level of real fold change data and minimal fold restriction
(Fd=Fa) in the Associative analysis leads to the loss of up to half of
all differentially expressed genes. The pre-processing procedures
(normalization, adjustment) are likely responsible for this loss
because even a slight decrease in expression level can reduce the
resulting fold change for a portion of genes below the established
cut off (Fd resulting,Fa), thereby increasing the number of false
negative selections. Figure 2B shows that, in the Associative
analysis, as the restriction on fold change (Fa) approaches (or even
exceeds) the real fold change (Fd), Sensitivity decreases signifi-
cantly, as would be expected in this situation.
Figure 2C shows that, at constant Fd/Fa of 2.0/1.5, the
Sensitivity of detection of differential expression drops as the
restriction for the minimum expression level (Em) decreases. This
behavior is due to excess of highly variable expression near the
Performance of Analyses
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expression has relatively little effect on the performance of the
Associative analysis.
In summary, the maximal level of Sensitivity does not exceeded
0.85 even under the best conditional situations. The controlled
changes introduced into real expression data do not necessary
make the changed expression really significantly different. The
statistical tests for differential expression analysis are based on the
difference in the expression level (Average) and its variation in
replicates (SD). A proportion of genes with extremely high
variation of the expression level is always present even in the very
homogeneous group of samples. The introduction of even
substantial difference for such genes does not cancel the fact of
their extreme variability. Being significantly different in the level of
expression (after controlled changes) such genes remain to be
extremely variable, and as a result could not be selected as
significantly different with any realistic differential analysis. The
selection and exclusion from analysis of such genes (with methods
presented in [19,24]) were able to elevate the Sensitivity level in
optimal variants in Figure 1 to the near 1 value (not shown) and
should be considered in the course of any analysis.
The influence of the number of replicates (Power
analysis)
The model presented here enables easy estimation of the
dependence of analysis quality on the number of replicates. The
results shown in Figure 3 demonstrate that in contrast to the
typically observed decrease in Specificity with decreasing numbers
of replicates (not shown) we observed no decrease in Precision as
the number of replicates was reduced. At the same time, the
Sensitivity of the analysis dropped significantly when the number
of replicates in each group drops below 4–5. The information
Figure 2. The influence of restrictions on the quality of differentially expressed genes detection (Fd - the level of introduced
changes, analysis restrictions on the minimal level of expression – Em, and fold change Fa). All results were obtained by application of
the Associative analysis (see Materials and Methods) to the analysis of data with controlled changes in expression of part of the genes. Sensitivity and
Precision are shown with bars of red and blue color correspondingly. A–B) Dependence of the Sensitivity on the relative values of introduced changes
(fold change Fd) and minimal fold change restriction for Associative analysis (Fa). Only fold change used in Associative analysis smaller than
introduced fold change Fd yielded highest Sensitivity and Precision. C) Decrease of the Sensitivity with decrease of the minimal expression level to
2SD of the normal distribution of technical noise. D) Relative stability of the quality of estimations over the whole range of gene expression levels.
doi:10.1371/journal.pone.0012657.g002
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required for the desired performance in an experimental design.
These estimations can be accurate and individually tailored for
specific microarray technologies, sources of mRNA, quality of
technological procedures, and other parameters. For example, in
the analysis presented here, a minimum of 4 replicates are
required to achieve about 80% Sensitivity for the detection of 2-
fold differences. This finding is a consequence of the high quality
of presented expression data and of the good performance of the
analytical procedure (Two-step normalization & Associative
analysis – see Materials and Methods). Larger fold changes can
be identified with even higher accuracy with the same number of
replicates.
The method presented in this study enables estimation of the
number of replicates required by using information about real
diversity in real preliminary data. All other methods of power
analysis use averaged estimations of gene expression variation
obtained in preliminary experiments.
Comparison of data preprocessing (normalization,
adjustment) and methods for differential gene
expression analyses
The effect of noisy technical variation in gene expression level in
the arrays can be minimized using normalization procedures.
However,the choiceofnormalization method can havea substantial
impact on the results of detection of differentially expressed genes.
Our method enables assessment of different normalization tech-
niques and their effects on the quality of the results.
Figure 4 compares the results of the Associative analysis applied
to the data subjected to different methods of normalization. These
comparisons (upper part of Figure 4) were performed using the 2-
fold balanced changes applied to 20% of the data from the
experimental subgroup (2-fold increase in 10% of the data and a
simultaneous 2-fold decrease in 10% of the neighboring data in
each 1000-gene block as shown in Figure 1, Supplemental Table
S4). Examples of analysis of the data with 10% and 5% balanced
changes (Supplemental Tables S2 and S3) are presented in
Supplemental Figure S1. Both Quantile and Lowess normaliza-
tions resulted in loss of the Sensitivity on highest expression levels.
VSN and 2-step normalizations have equally good Sensitivity in
this area however for the rest of the expression levels VSN
demonstrated lower levels and lower stability of Sensitivity
compared with 2-step normalization. Little difference in Precision
is seen for all three methods excluding VSN, which again shows
drop in level and stability.
In case of asymmetrical changes there was practically complete
loss of Sensitivity and Precision for Quantile and Lowess for genes
with highest expression levels (Figure 4C, D). In fact there was
severe degradation of the Precision in the analysis of the data
normalized by all these procedures (Figure 4D).
Several modified statistics have been proposed for analysis of the
significance of differences in gene expression. Of these, SAM [25]
is arguably the most popular. We compared SAM with two other
procedures – Associative analysis [18,19] and Limma [26]. These
comparisons were performed using the 2-fold balanced changes
applied the 20% of raw data (see above) with subsequent 2-step
normalization (Materials and Methods). The results are shown in
Figure 5 (Analyses for 10% and 5% are shown in the
Supplemental Figure S2). All three methods demonstrate similar
patterns of Sensitivity and Precision, however, Limma analysis
produces much less reproducible results. The loss of reproducibil-
ity and decrease of Sensitivity were seen also in case 10% and 5%
changes (Supplemental Figure S2A, C) for both SAM and Limma
methods. Associative analysis demonstrates essential loss of
Precision compared with other methods (Supplemental Figure
S2B, D). The same loss of Precision was seen also in case of
asymmetrical changes (2-fold increase in 10% data) – Figure 5D.
We would like to note however, that all these positive conclusions
about performance of SAM and Limma methods were obtained
with use of 2-step normalization procedure, which demonstrated
better performance in the most important area of highest gene
expression (Figure 4 and Supplemental Figure S1). Published
microarray data analyses usually used the combination of SAM
and Limma methods with popular Quantile and Lowess
normalizations. Poor performance of these normalizations at high
gene expression area is able to deteriorate essentially the overall
quality of such combinations in gene expression analyses (Figure 5).
Discussion
Rapid development of microarray technology over the past
decade has produced a number of methods for data pre-processing
and selection that can be used to identify differentially expressed
genes in microarray datasets. Importantly, different analytical
methods frequently identify different lists of differentially expressed
genes. Although numerous reviews have examined the details of a
variety of different methods [5,14,25] only a few publications have
addressed the issue of direct quantitative comparisons of different
methods. Despite the fact that ROC-curves [1,2,3] can be used to
characterize overall performance of different array platforms and
software packages, practical use of this comparison is limited due
to the lack of a priori knowledge of the number of true positive and
true negative genes in a given dataset. Verification of the
differences in gene expression using experimental techniques such
as RT-PCR cannot solve this problem because this approach only
verifies a subset of true positives but does not provide any
information about the number of true and false positives in the
entire dataset [25]. Several studies have analyzed simulated
datasets containing a known number of truly regulated genes
[5,6,7,8,9]. However, it is unclear whether these simulated datasets
realistically reflect the complex structure of real microarray data.
Figure 3. The influence of the number of replicates (Power
analysis). Dependence of the quality of Associative analysis (Fa=1.5,
Em=20) from the number of replicates is shown for different
introduced fold changes Fd (X axis - Precision on the left side, and Y
axis - Sensitivity on the right side). The results are obtained as an
average of the analysis of three bootstrapped datasets and expressed as
mean/SD.
doi:10.1371/journal.pone.0012657.g003
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introduce controlled changes in hybridization/expression of a
known portion of the genes in an array experiment. However, this
technique remains expensive and restricted in its applicability. An
essential drawback of the spike-in experiments involves the non-
linearity of probe effects. Deviation from linearity near minimum
detectable level and saturation level can misrepresent the results of
the performance estimation [10]. This drawback is usually
overcome by titration of the probes over a wide range of
concentrations to obtain linear data for use in the comparative
analysis. The necessity for titration makes this method expensive,
lengthy and difficult for interpretation.
We have presented a methodology for quantitative estimation of
the effects of pre-processing procedures and data analysis methods
on the detection of true differentially expressed genes. The greatest
strength of our strategy is the creation of test datasets through the
introduction of controlled changes into real gene expression data.
The methodology presented here is universal and can be applied
to any existing microarray technology, any source of sample
material and any experimental design. The use of real gene
Figure 4. Comparison of normalization methods. The dataset was split into two equal subgroups, one of which remains unchanged and is
used as a standard for comparison. The second subgroup is altered by introduced fold changes in the portion of gene expression. Four different
normalizations were applied to the resulting data: Two-step normalization, Quantile, Lowess, and VSN. Associative analysis (see Materials and
Methods) was used for the selection of differentially expressed genes with Fd/Fa/Em=2/1.5/20 restrictions in all these cases. The procedure was
repeated three times (every time with different arbitrary split of 20 samples data into 10&10 samples subgroups) and the averages and SD of the
estimations are shown. A) Sensitivity and B) Precision (Y axes) for symmetrical changes in gene expression (2-fold increase in 10% and 2-fold decrease
in another 10% of data). C) Sensitivity and D) Precision for asymmetric changes in gene expression (2-fold increases in 10% of gene expressions only).
X axis shows the positions of the blocks of gene expression data used for the parameters estimations (in percentage along decreasingly sorted data,
i.e. the 99–100 interval presents 1% of the genes with the highest expressions in the array).
doi:10.1371/journal.pone.0012657.g004
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(expression level profile, variation patterns, and even typical for
the technology errors etc.) is a great advantage of this approach
over similar attempts that have used simulated data or artificial
models based on the use of simplified/averaged statistical
characteristics from real experiments. Introduction of controlled
changes into the expression dataset enables us to address many
problems associated with pre-processing and analysis of micro-
array data, including the quality dependence of the analysis from
the threshold of minimal gene expression, the influence of fold
change restrictions, and other factors. Further, the introduction of
controlled changes completely eliminates the problem of non-
linearity of probe effects because the changes are introduced into
the final expression levels as if they were measured in the linear
region of the dose/response dependence curve. We believe that
the use our comparative approach will improve the robustness of
microarray-based experiments.
Homogeneous real gene expression data from any experiment
can be used to create a transformed dataset with controlled
balanced changes introduced into a portion of the genes measured
in the array. Similar microarray data matching the manufacturer,
organism, tissue/cells can almost always be found among
.400,000 microarray samples stored on Gene Expression
Omnibus (GEO, [16]), if such data were not included in the
initial experimental design.
Homogeneity of the initial data set will influence estimations of
the performance of the analyses. Estimation of true and false
selections are based on the proposition that after arbitrarily chosen
split the resulting subgroups have only changes in gene expression
produced mainly by the controlled modifications in one of the
Figure 5. Comparison of different methods for gene expression analysis. Sensitivity/Precision of Limma, SAM and Associative analyses. The
2-step normalization procedure was used in all cases. The restrictions were Fd/Fa/Em=2/1.5/20. A) Sensitivity and B) Precision for symmetrical
changes in gene expression (2-fold increases and 2-fold decreases in gene expressions were equally presented). C) Sensitivity and D) Precision for
asymmetric changes in gene expression (2-fold increases in 10% portion of gene expressions). Axes designation is the same as in Figure 4.
doi:10.1371/journal.pone.0012657.g005
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types of outliers even within most homogeneous biological data.
The approach presented here is especially sensitive to the presence
of genes having extremely variable expressions [27], which could
not be presented equally after arbitrary split of the group into two
subgroups for subsequent controlled changes and analysis. The
best strategy to estimate and minimize the influence of such genes
is to repeat the procedure several times with random permutation
of the order of samples within the group before each split. The
results (Sensitivity/Precision) will be presented in form of means
+/2 SD as shown in Figures 2, 4, 5 and 6. The ‘‘outliers’’ in our
data did not interfere essentially with our tests, as very small
variation in the Sensitivity/Precision estimations was seen in many
cases (see for example 2–step normalization in conjunction with
Associative analysis – Figures 4, 5). Still, the ‘‘outliers’’ can make
more significant influence in some practical cases, especially
associated with the analysis of quite heterogeneous clinical data.
However, even in such cases it is possible to compare different
methods of analysis as they will be still in the same equal
conditions. The presence of ‘‘outliers’’ is a reality of practical
analysis that usually is not estimated and ignored. The use of the
multiple arbitrary splits and analysis of resulting differences in
gene expressions between ‘‘equal’’ subgroups (before introduced
changes) will help to observe real non-homogeneity and estimate
its contribution into all subsequent results.
To demonstrate the potential of our proposed methodology we
performed quantitative comparisons of the efficiencies of different
normalization and analysis methods. The presented results enable
Figure 6. Comparison of different methods for gene expression analysis in conjunction with normalization procedures usually used
with these methods. The results are shown for symmetric (A, B) and asymmetric (C, D) changes in gene expressions for combinations
Quantile&Limma, Lowess&Limma, Quantile&SAM, Lowess&SAM, and 2-step normalization&Associative analysis. All details of experiments and
designations are as in Figure 5.
doi:10.1371/journal.pone.0012657.g006
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the wide ranges of gene expression levels and estimate stability of
the characteristics of the performance (Sensitivity and Precision).
This analysis is based on the use of preliminary data. However, if
the user is unable to run several microarray experiments to
estimate the robustness of specific pre-processing and statistical
analysis methods, real data that mimic the experimental conditions
can be freely obtained from public microarray data repositories
(GEO [16], ArrayExpress [28]).
The question ‘how many replicates is enough?’ is complicated
by many potentially confounding factors such as the type of array
equipment, laboratory technique, and, most importantly, the
quality of the samples. Cost often represents a significant restraint
and it is important to know which fold changes can be detected
reliably for a given number of replicates. Our analytical approach
can be used to objectively estimate the number of replicates of a
microarray experiments required to reach any desired quality of
analysis and can be completely adjusted to the technological
platform and experimental design.
In summary, we present an accurate and universal procedure
for quantitative and qualitative estimation of the methods of
microarray data analysis. Our approach has the potential for
broad applicability to different types of arrays, including those with
asymmetric distributions of up/down-regulated genes. All pro-
grams used for our analysis were written in MATLAB and are
available upon request. The microarray data containing balanced
2-fold differences in the levels of expression of 20% of the genes
measured are provided as Supplemental material (Table S1) and
may be used by readers for quality analysis estimation of their own
analytical methods. The main result of the presented here analyses
were reproduced without essential differences with smaller
proportion of the controlled changes (5% and 10%, Supplemental
material).
Supporting Information
Figure S1 Comparison of normalization methods. Two-step
normalization vs. Quantile, Lowess, and VSN normalizations. All
designations are as in Figure 4. Associative analysis was used for
the selection of differentially expressed genes with Fd/Fa/Em=2/
1.5/20 restrictions in all cases. A) Sensitivity and B) Precision (Y
axis) for 2-fold symmetric changes of 10% gene expressions. C)
Sensitivity and D) Precision for symmetric changes in 5% gene
expressions.
Found at: doi:10.1371/journal.pone.0012657.s001 (0.73 MB TIF)
Figure S2 Comparison of different methods for gene expression
analysis. Limma, SAM and Associative analysis performance
compared in terms of Sensitivity/Precision. 2-step normalization
procedure was used in all cases. The restrictions were Fd/Fa/
Em=2/1.5/20 as before. A) Sensitivity and B) Precision for
symmetric changes in 10% of gene expression; C) and D) - the
same for 5% changes.
Found at: doi:10.1371/journal.pone.0012657.s002 (0.58 MB TIF)
Table S1 Raw data (before normalization) without introduced
changes. In this research we used the group of arrays created from
20 samples from Epstein-Barr Virus (EBV)-transformed B cells
collected from normal healthy donors (Illumina Whole Genome,
Human Ref-8 V2.0 arrays containing over 20,000 genes). This
presumably homogenous group was split into two equal
subgroups. One of the subgroups (columns Q-Z) was used as a
control, whereas the artificial changes in gene expressions were
introduced in another subgroup (experimental - G-P columns). All
data were sorted by the average expression in experimental group.
Found at: doi:10.1371/journal.pone.0012657.s003 (6.30 MB
XLSX)
Table S2 Data with introduced symmetrical 2-fold differences in
5% of the expression in one half of samples. Column AA
(Modifications) shows the changed gene expression: 1 - means 2-
fold increase of expression, and 2- 2-fold decrease, zero means
unmodified data. Data with increase/decrease of expression are
highlighted red/blue, respectively.
Found at: doi:10.1371/journal.pone.0012657.s004 (6.45 MB
XLSX)
Table S3 Data with introduced symmetrical 2-fold differences in
10% of the expression in one half of samples. Column AA
(Modifications) shows the changed gene expression: 1 - means 2-
fold increase of expression, and 2- 2-fold decrease, zero means
unmodified data. Data with increase/decrease of expression are
highlighted red/blue, respectively.
Found at: doi:10.1371/journal.pone.0012657.s005 (6.46 MB
XLSX)
Table S4 Data with introduced symmetrical 2-fold differences in
20% of the expression in one half of samples. Column AA
(Modifications) shows the changed gene expression: 1 - means 2-
fold increase of expression, and 2- 2-fold decrease, zero means
unmodified data. Data with increase/decrease of expression are
highlighted red/blue, respectively.
Found at: doi:10.1371/journal.pone.0012657.s006 (6.41 MB
XLSX)
Table S5 Data with introduced asymmetrical 2-fold increase
only in 10% of the expression in one half of samples. Column AA
(Modifications) shows the changed gene expression: 1 - means 2-
fold increase of expression, zero means unmodified data. Data
with increase of expression are highlighted red.
Found at: doi:10.1371/journal.pone.0012657.s007 (6.45 MB
XLSX)
Table S6 The raw data (before normalization) with introduced
asymmetrical 4-fold increase 10% of the expression and 2-fold
decrease in another 10% of the expression in one half of the data.
Column AA (Modifications) shows the changed gene expression:
1 - means 4-fold increase of expression, 2 - means 2-fold decrease
of expression, zero means unmodified data. Data with increase/
decrease of expression are highlighted red/blue, respectively.
Found at: doi:10.1371/journal.pone.0012657.s008 (6.30 MB
XLSX)
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